Pfizer, FDA Continue Talks on Breast-Cancer Drug

Pfizer said it is continuing to talk with the U.S. Food and Drug Administration about the company’s application for palbociclib, its experimental breast-cancer treatment.



from WSJ.com: US Business http://ift.tt/1xVwT4M

via IFTTT